- SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
-
Saucedo-Orozco H, Voorrips SN, Yurista SR, de Boer RA, Westenbrink BD
- KMID: 2525232
- J Lipid Atheroscler.
- 2022 Jan;11(1):1-19.
- doi: 10.12997/jla.2022.11.1.1
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as powerful drugs that can be used to treat heart failure (HF) patients, both with preserved and reduced ejection fraction and in the presence... -
- CITED
-
- Close
- SHARE
-
- Close
